Modified bacterial outer membrane vesicles induce autoantibodies for tumor therapy

Biological properties of extracellular vesicles and their physiological functions

María Yáñez‐Mó, Pia Siljander, Zoraida Andreu et al. · Journal of Extracellular Vesicles · 2015 · 5.9K citations · Full text

Life Sciences, Cell Biology, Physiology +16

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Oriol Casanovas, Daniel J. Hicklin, Gabriele Bergers et al. · Cancer Cell · 2005 · 1.6K citations · Full text

Medicine, Oncology, Pharmacology +16

AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance

Thomas O’Hare, William C. Shakespeare, Xiaotian Zhu et al. · Cancer Cell · 2009 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +9

Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy

Vipul Gujrati, Sung-Hyun Kim, Sang‐Hyun Kim et al. · ACS Nano · 2014 · 529 citations

Pharmacy, Oncology, Pharmaceutics +17

Multi-Kinase Inhibitor E7080 Suppresses Lymph Node and Lung Metastases of Human Mammary Breast Tumor MDA-MB-231 via Inhibition of Vascular Endothelial Growth Factor-Receptor (VEGF-R) 2 and VEGF-R3 Kinase

Junji Matsui, Yasuhiro Funahashi, Toshimitsu Uenaka et al. · Clinical Cancer Research · 2008 · 528 citations · Full text

Medicine, Oncology, Pharmacology +17